Acacetin protects against cardiac remodeling after myocardial infarction by mediating MAPK and PI3K/Akt signal pathway

Since inhibiting cardiac remodeling is a critical treatment goal after myocardial infarction (MI), many drugs have been evaluated for this purpose. Acacetin is a flavonoid compound that has been shown to have anti-cancer, anti-mutagenic, anti-inflammatory and anti-peroxidative effects. In this study...

Full description

Bibliographic Details

Published in:	Journal of Pharmacological Sciences
Main Authors:	Wei Chang, Qing-Qing Wu, Yang Xiao, Xiao-Han Jiang, Yuan Yuan, Xiao-Feng Zeng, Qi-Zhu Tang
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Subjects:	Acacetin Coronary ligation Myocardial infarction Cardiac remodeling Cardiac protection
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861317301949